Verition Fund Management LLC Maravai Lifesciences Holdings, Inc. Transaction History

Verition Fund Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$6.87 - $11.34 $412,454 - $680,819	60,037 New	60,037 $429,000
Q2 2023 Aug 14, 2023	BUY	$12.09 - $15.0 $1.69 Million - $2.1 Million	139,955 Added 1000.32%	153,946 $1.91 Million
Q1 2023 May 15, 2023	SELL	$12.99 - $16.48 $115,507 - $146,540	-8,892 Reduced 38.86%	13,991 $196,000
Q4 2022 Feb 14, 2023	BUY	$12.5 - $24.78 $286,037 - $567,040	22,883 New	22,883 $327,000
Q2 2022 Aug 15, 2022	BUY	$26.05 - $37.48 $156,821 - $225,629	6,020 Added 22.96%	32,244 $916,000
Q1 2022 May 13, 2022	BUY	$24.46 - $40.92 $641,439 - $1.07 Million	26,224 New	26,224 $925,000
Q3 2021 Nov 15, 2021	SELL	$36.8 - $60.62 $215,279 - $354,627	-5,850 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$32.46 - $45.0 $189,891 - $263,250	5,850 New	5,850 $244,000

234

140M

223K

19.4K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $738M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.